Close

Articles Posted in Personal Injury

Updated:

FDA Warns Pfizer For Lax Oversight of Geodon Drug Study

Federal regulators say the drugmaker Pfizer has failed to correct problems with its testing procedures that resulted in overdoses of several children during a company trial. The Food and Drug Administration issued a warning letter saying Pfizer did not properly monitor physicians testing an experimental medication, which the agency did…

Updated:

Life Time Fitness Company Sues Mother of Drowned Boy

Two years ago, 4-year-old Colin Holst drowned in a Life Time Fitness swimming pool surrounded by adults and lifeguards. After being hit with a $25 million wrongful death lawsuit by Colin’s parents, Life Time is suing Colin’s mother and two of her friends, accusing them of trespassing, fraud and breach…

Updated:

NUVARING® Manufacturers and Distributors Sued for Wrongful Death

Many lawsuits have been filed against the pharmaceutical companies associated with the birth control product NUVARING® in the United States. NUVARING® is a birth control product that releases two synthetic hormones, etonogestrel (a progestin) and ethinyl estradiol (an estrogen), into the woman’s body. The lawsuit complaints allege that the parties…

Updated:

ENDOSCOPY CENTER OUTBREAK: Hepatitis C case goes to trial

Robert Eglet’s client, is infected with hepatitis C, and his Las Vegas law firm going head to head with one of the largest drugmakers in the world and its international law firm. It’s a battle that began more than two years ago after local health officials announced a hepatitis C…

Updated:

Yaz, Yasmin, Ocella Concerns Bring Lawsuits But Few Answers

When the oral contraceptives Yasmin and Yaz came on the market in 2001 and 2006, respectively, they were thought to be safer than other birth control pills because they contained a different kind of synthetic progestin. But in the lawsuits against the pills’ maker, Bayer HealthCare, plaintiff attorneys claim that…

Updated:

Bayer Told to Revise Yaz, Yasmin Marketing Materials

Federal regulators are requiring Bayer Healthcare to revise its marketing materials for Yaz and Yasmin to reflect new safety information that was recently added to the drugs’ labels. In a letter to Bayer dated April 7, the Food & Drug Administration (FDA) said revisions must include “prominent disclosure of the…

Updated:

NuvaRing Named in 300 Product Liability Lawsuits

NuvaRing, a contraceptive device marketed by Organon Pharmaceuticals and Merck & Co., has been named in some 300 product liability lawsuits. The lawsuits claim that NuvaRing caused plaintiffs to suffer serious, life-threatening blood clots. NuvaRing is a transparent, flexible vaginal ring that provides month-long birth control by emitting a continuous…

Contact Us
Start Chat